Canada Life’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-12,256
Closed -$128K 2287
2023
Q1
$128K Sell
12,256
-3,952
-24% -$41.3K ﹤0.01% 1944
2022
Q4
$548K Buy
16,208
+210
+1% +$7.1K ﹤0.01% 1697
2022
Q3
$765K Buy
15,998
+3,466
+28% +$166K ﹤0.01% 1579
2022
Q2
$713K Buy
12,532
+1,912
+18% +$109K ﹤0.01% 1598
2022
Q1
$880K Hold
10,620
﹤0.01% 1560
2021
Q4
$2.15M Buy
10,620
+4,858
+84% +$984K ﹤0.01% 1168
2021
Q3
$1.56M Buy
5,762
+1,046
+22% +$283K ﹤0.01% 1319
2021
Q2
$1.21M Buy
4,716
+12
+0.3% +$3.09K ﹤0.01% 1425
2021
Q1
$1.41M Sell
4,704
-243
-5% -$72.8K ﹤0.01% 1347
2020
Q4
$1.26M Sell
4,947
-728
-13% -$185K ﹤0.01% 1401
2020
Q3
$1.41M Sell
5,675
-302
-5% -$75K ﹤0.01% 1238
2020
Q2
$2.08M Sell
5,977
-108
-2% -$37.5K ﹤0.01% 1050
2020
Q1
$1.63M Buy
6,085
+434
+8% +$116K ﹤0.01% 1053
2019
Q4
$1.82M Buy
5,651
+1,145
+25% +$368K ﹤0.01% 1190
2019
Q3
$1.23M Sell
4,506
-9
-0.2% -$2.46K ﹤0.01% 859
2019
Q2
$2.41M Sell
4,515
-120
-3% -$64K 0.01% 1072
2019
Q1
$2.33M Sell
4,635
-849
-15% -$427K 0.01% 959
2018
Q4
$2.56M Buy
5,484
+59
+1% +$27.5K 0.01% 883
2018
Q3
$4.96M Buy
5,425
+135
+3% +$124K 0.01% 700
2018
Q2
$3.87M Buy
5,290
+2,463
+87% +$1.8M 0.01% 805
2018
Q1
$4.51M Sell
2,827
-10,831
-79% -$17.3M 0.01% 734
2017
Q4
$12.2M Sell
13,658
-547
-4% -$490K 0.03% 470
2017
Q3
$5.05M Sell
14,205
-676
-5% -$240K 0.01% 691
2017
Q2
$4.36M Buy
14,881
+618
+4% +$181K 0.01% 722
2017
Q1
$5.02M Buy
14,263
+930
+7% +$327K 0.01% 691
2016
Q4
$2.46M Buy
13,333
+1,088
+9% +$200K 0.01% 966
2016
Q3
$3.15M Buy
12,245
+504
+4% +$130K 0.01% 822
2016
Q2
$2.5M Buy
11,741
+10,768
+1,107% +$2.3M 0.01% 901
2016
Q1
$200K Buy
973
+315
+48% +$64.7K ﹤0.01% 1317
2015
Q4
$166K Hold
658
﹤0.01% 1396
2015
Q3
$108K Hold
658
﹤0.01% 1648
2015
Q2
$123K Hold
658
﹤0.01% 1712
2015
Q1
$108K Hold
658
﹤0.01% 1751
2014
Q4
$153K Hold
658
﹤0.01% 1458
2014
Q3
$120K Hold
658
﹤0.01% 1545
2014
Q2
$126K Hold
658
﹤0.01% 1412
2014
Q1
$119K Buy
658
+341
+108% +$61.7K ﹤0.01% 1351
2013
Q4
$54K Buy
+317
New +$54K ﹤0.01% 1739